Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DUOBRII 0.01%-0.045% LOTION

halobetasol propionate and tazarotene
$10.0097per GM

Strength

.1; .45 mg/g; mg/g

Manufacturer

Bausch Health US LLC

NDC

00187065301

Classification

Brand

Dosage Form

LOTION

Route

TOPICAL

Last Updated

9/17/2025

Active Ingredients

HALOBETASOL PROPIONATE; TAZAROTENE

Approval Type

New Drug (NDA)

FDA Application

NDA209354

On Market Since

4/25/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid
Retinoid
Retinoids

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.3%

3Y

+3.1%

5Y

+19.7%

All

+25.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

PREPARATION H HC 1% CREAM
Brand
00573283010•Haleon US Holdings LLC
$0.2072
per GM
MEDROL 4 MG TABLET
Brand
00009005602•Pharmacia & Upjohn Company LLC
$0.2257
per EA
DERMA-SMOOTHE-FS SCALP OIL
Brand
68791010204•Royal Pharmaceuticals
$0.2423
per ML
DERMA-SMOOTHE-FS BODY OIL
Brand
68791010104•Royal Pharmaceuticals
$0.2426
per ML
MEDROL 4 MG DOSEPAK
Brand
00009005604•Pharmacia & Upjohn Company LLC
$0.2911
per EA
DIFFERIN 0.1% GEL
Brand
00299491045•Galderma Laboratories, L.P.
$0.4639
per GM
DIFFERIN 0.1% GEL
Brand
00299491015•Galderma Laboratories, L.P.
$0.7045
per GM
RETIN-A 0.05% CREAM
Brand
00187516245•Bausch Health US LLC
$0.7904
per GM
RETIN-A 0.025% CREAM
Brand
00187516045•Bausch Health US LLC
$0.7904
per GM
RETIN-A 0.025% CREAM
Brand
00187516020•Bausch Health US LLC
$0.7907
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy